The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 06, 2007
Filed:
Oct. 16, 2002
Georg Dahmann, Attenweiler, DE;
Frank Himmelsbach, Mittelbiberach, DE;
Bernd Krist, Vienna, AT;
Martin Lenter, Ulm, DE;
Alexander Pautsch, Biberach, DE;
Gisela Schnapp, Biberach-Rindenmoos, DE;
Martin Steegmaier, Vienna, AT;
Helmut Wittneben, Schriesheim, DE;
Anthony S. Prokopowicz, Beekman, NY (US);
Walter Spevak, Oberrohrbach, AT;
Andreas Schoop, Vienna, AT;
Steffen Steurer, Vienna, AT;
Georg Dahmann, Attenweiler, DE;
Frank Himmelsbach, Mittelbiberach, DE;
Bernd Krist, Vienna, AT;
Martin Lenter, Ulm, DE;
Alexander Pautsch, Biberach, DE;
Gisela Schnapp, Biberach-Rindenmoos, DE;
Martin Steegmaier, Vienna, AT;
Helmut Wittneben, Schriesheim, DE;
Anthony S. Prokopowicz, Beekman, NY (US);
Walter Spevak, Oberrohrbach, AT;
Andreas Schoop, Vienna, AT;
Steffen Steurer, Vienna, AT;
Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, DE;
Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT (US);
Abstract
The present invention relates to trisubstituted pyrimidines of formula (I) wherein0Rto Rare defined as in claim 1, which are suitable for the treatment of illnesses characterised by excessive or abnormal cell proliferation, the use thereof for preparing a pharmaceutical composition with the abovementioned properties, and processes for the preparation thereof.